MONITORING DRUG SAFETY

被引：0
|
作者：
不详
机构：
来源：
LANCET | 1979年 / 1卷 / 8128期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1252 / 1252
页数：1
相关论文
共 50 条
  • [21] Drug monitoring of lamotrigine increases drug safety of concomitant use with valproate
    Greiner, C.
    Bader, W.
    Melchner, D.
    Haen, E.
    DRUG SAFETY, 2006, 29 (10) : 942 - 942
  • [22] FDA drug labeling for pregnancy and lactation drug safety monitoring systems
    Greene, Michael F.
    SEMINARS IN PERINATOLOGY, 2015, 39 (07) : 520 - 523
  • [23] On Quantitative Methods for Clinical Safety Monitoring in Drug Development
    Wang, William
    Whalen, Ed
    Munsaka, Melvin
    Li, Judy
    Fries, Michael
    Kracht, Karolyn
    Sanchez-Kam, Matilde
    Singh, Krishan
    Zhou, Kefei
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2018, 10 (02): : 85 - 97
  • [24] The Role of Clinical Registries in Monitoring Drug Safety and Efficacy
    Reid, Christopher M.
    HEART LUNG AND CIRCULATION, 2015, 24 (11): : 1049 - 1052
  • [25] Therapeutic Drug Monitoring on the Safety of Sirolimus in Transplant Patients
    Minareci, Edibe
    Eurasian Journal of Medicine, 2016, 48 (03): : 234 - 234
  • [26] Monitoring liver safety in drug development: The GSK experience
    Hunt, Christine M.
    Papay, Julie I.
    Edwards, Rita I.
    Dickens, Theodore
    Alpers, David H.
    Dollery, Colin
    DeBruin, Tjerk W.
    Adkison, Kimberly K.
    Stirnadel, Heide A.
    Gibbs, Trevor G.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2007, 49 (02) : 90 - 100
  • [27] Nonsteroidal antiinflammatory drug toxicity monitoring and safety practices
    Patino, FG
    Olivieri, J
    Allison, JJ
    Mikuls, TR
    Moreland, L
    Kovac, SH
    Juarez, L
    Person, S
    Curtis, J
    Saag, KG
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (12) : 2680 - 2688
  • [28] Dabigatran: safety, usefulness and practical details of drug monitoring
    Mullier, F.
    Douxfils, J.
    Robert, S.
    Devel, P.
    Chatelain, C.
    Chatelain, B.
    Dogne, J-M
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 857 - 857
  • [29] Large-scale drug safety monitoring feasible?
    Reactions Weekly, 2011, 1343 (1) : 2 - 2
  • [30] Monitoring drug safety; Cardiac events in routine mydriasis
    Gaynes, BI
    OPTOMETRY AND VISION SCIENCE, 1998, 75 (04) : 245 - 246
12345